{
    "organizations": [],
    "uuid": "052a53b4462bc468de6070a4acfbc7a8d61c90f6",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-foundation-medicines-new-liquid-bi/brief-foundation-medicines-new-liquid-biopsy-assay-granted-breakthrough-device-designation-by-u-s-fda-idUSFWN1S30VT",
    "ord_in_thread": 0,
    "title": "Foundation Medicine's New Liquid Biopsy Assay Granted Breakthrough Device Designation By U.S. FDA",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 26 (Reuters) - Foundation Medicine Inc:\n* FOUNDATION MEDICINEâ€™S NEW LIQUID BIOPSY ASSAY GRANTED BREAKTHROUGH DEVICE DESIGNATION BY U.S. FOOD AND DRUG ADMINISTRATION\n* FOUNDATION MEDICINE- NEW ASSAY WILL INCLUDE OVER 70 GENES, GENOMIC BIOMARKERS FOR MICROSATELLITE INSTABILITY & BLOOD TUMOR MUTATIONAL BURDEN Source text for Eikon:\n ",
    "published": "2018-04-26T19:10:00.000+03:00",
    "crawled": "2018-04-27T16:52:27.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "foundation",
        "medicine",
        "inc",
        "foundation",
        "medicine",
        "new",
        "liquid",
        "biopsy",
        "assay",
        "granted",
        "breakthrough",
        "device",
        "designation",
        "food",
        "drug",
        "administration",
        "foundation",
        "new",
        "assay",
        "include",
        "gene",
        "genomic",
        "biomarkers",
        "microsatellite",
        "instability",
        "blood",
        "tumor",
        "mutational",
        "burden",
        "source",
        "text",
        "eikon"
    ]
}